Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD

Abstract Inhaled fixed-dose combinations (FDCs) of a long-acting β-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) have become the cornerstone for the maintenance treatment of symptomatic COPD patients. In this regard, global COPD treatment guidelines have recognized the importance of...

Full description

Bibliographic Details
Main Authors: Anthony D’Urzo, Kenneth R. Chapman, James F. Donohue, Peter Kardos, M. Reza Maleki-Yazdi, David Price
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-03-01
Series:Pulmonary Therapy
Subjects:
Bronchodilation
Chronic obstructive pulmonary disease
Combination bronchodilator agents
Inhalers
LABA
LAMA
Online Access:http://link.springer.com/article/10.1007/s41030-019-0090-1

Internet

http://link.springer.com/article/10.1007/s41030-019-0090-1

Similar Items